Diabetes has emerged as one of the largest global epidemics; it is estimated that by 2035, there will be 592 million diabetic people in the world. Brazilian biodiversity and the knowledge of traditional peoples have contributed to the treatment of several diseases, including diabetes. Apis mellifera bee tea is used by indigenous Brazilians to treat diabetes, and this traditional knowledge needs to be recorded and studied.The objective of this study was to record the use and to evaluate the antioxidant, antihyperglycemic, and antidiabetic activity of Apis mellifera bee tea, which is used by the Guarani and Kaiowá indigenous people for the treatment of diabetes. Semi-structured interviews were performed with Guarani and Kaiowá ethnic indigenous people from the State of Mato Grosso do Sul, Brazil, seeking to identify the animal species used for medicinal purposes. For the experimental procedures, tea prepared with macerated Apis mellifera bees was used. In vitro assays were performed to evaluate antioxidant activity; direct free radical scavenging, protection against oxidative hemolysis, lipid peroxidation were evaluated in human erythrocytes and potential in inhibiting the formation of advanced glycation end products (AGEs). In vivo, normoglycemic Swiss male mice treated with Apis mellifera tea (AmT) were subjected to the oral glucose tolerance test and compared with control and metformin-treated groups. Diet-induced diabetic mice were treated for 21 days with AmT and evaluated for glycemia and malondialdehyde levels in the blood, liver, nervous system, and eyes. During interviews, the indigenous people described the use of Apis mellifera bee tea for the treatment of diabetes. In in vitro assays, AmT showed direct antioxidant activity and reduced oxidative hemolysis and malondialdehyde generation in human erythrocytes. The AmT inhibited the formation of AGEs by albumin-fructose pathways and methylglyoxal products. In vivo, after oral glucose overload, normoglycemic mice treated with AmT had reduced hyperglycemia at all times evaluated up to 180 min. AmT also reduced hyperglycemia and malondialdehyde levels in the blood, liver, nervous system, and eyes of diabetic mice to similar levels as those in metformin-treated mice and normoglycemic controls. In summary, Apis mellifera bee tea showed antioxidant, antihyperglycemic, and antidiabetic activity, which provides support for the therapeutic application of Guarani and Kaiowá indigenous knowledge.
Citation: Melo da Cunha JdS, Alfredo TM, dos Santos JM, Alves Junior VV, Rabelo LA, Lima ES, et al. (2018) Antioxidant, antihyperglycemic, and antidiabetic activity of Apis mellifera bee tea. PLoS ONE 13(6): e0197071. https://doi.org/10.1371/journal.pone.0197071
Editor: M. Faadiel Essop, Stellenbosch University, SOUTH AFRICA
Received: August 31, 2017; Accepted: April 25, 2018; Published: June 5, 2018
Copyright: © 2018 Melo da Cunha et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: This work was supported by grants from Foundation to Support to Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT) - http://fundect.ledes.net/; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) - http://www.capes.gov.br/; Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) – http://www.cnpq.br/; and Funding announcement FUNDECT/CAPES no. 27/2015 – PAPOS FASE II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
In Brazil, several animal species are used for medicinal purposes in folk medicine and by indigenous communities , and much of this knowledge has not been scientifically described or proven . The zootherapeutic knowledge of the Guarani and Kaiowá ethnic groups, who are located in the center-west region of Brazil, has not been sufficiently studied.
Thus, we chose to study the zootherapy used by the Guarani and Kaiowá ethnicities, who reported the use of Apis mellifera bee tea for the treatment of diabetes. Research on zootherapy is very important for cultural maintenance and to measure pharmacological effects [1,2,3].
Apiculture substances have been used since ancient times for many therapeutic purposes . Examples include the use of honey in the treatment of wounds and burns [5,6], propolis as an antioxidant and antitumor agent [7,8], and bee venom for the reduction of complications arising from diabetes, which is an effect mediated by decreased human hemoglobin glycation . In addition, some components isolated from bee venom, such as melittin, have anti-inflammatory and anti-carcinogenic effects [10,11], and tryptophan suppresses the elevation of blood glucose and preserves the insulin secretion from β-cells , and also considered a new marker associated with diabetes decreased risk .
In this context, several products derived from bees have been used in the prevention and treatment of diseases related to oxidative stress and diabetes [14,15,16]. The antioxidants are capable of directly enhancing the endogenous defense system  and modulating the enzymatic systems [18, 19] involved in reducing reactive species, especially reactive oxygen species (ROS). These activities ultimately prevent cell damage resulting from cell membrane lipid peroxidation , the oxidation of hormone receptors , and changes in the genetic material , which can lead to irreversible systemic damage such as nephropathy , retinopathy , and peripheral neuropathy . These complications, in addition to their individual relevance, are aggravated in the context of diabetes [26, 27].
It is estimated that the global prevalence of diabetes will increase from 382 to 592 million people between 2013 and 2035  because of factors such as aging, sedentary lifestyle, eating habits, and obesity. Obesity is associated with the increased production of ROS species [29, 30], and it is one of the main risk factors for the development of type 2 diabetes, which is characterized by insulin resistance and imbalanced glycemic homeostasis [31,32,33].
From this perspective, this is the first study that describes and evaluates the antioxidant, antihyperglycemic, and antidiabetic activity of Apis mellifera bee tea used by Guarani and Kaiowá indigenous people for the treatment of diabetes.
Materials and methods
Semi-structured interviews (S1 Text) were conducted to record information on the species and animal resources used in the traditional medicine of the indigenous peoples of the Guarani and Kaiowá ethnic groups living in Mato Grosso do Sul, Brazil. Twenty (20) students of the Federal University of Grande Dourados (UFGD, Dourados, Brazil) belonging to the Guarani and Kaiowá ethnic groups consented to interviews (authorized by the Ethics Committee for research involving human subjects of UFGD under No. 1.858.827).
The Guarani and Kaiowá ethnic groups are distributed in 21 of the 79 municipalities of Mato Grosso do Sul; together they account for an estimated population of 42,000 and represent the second largest indigenous population of Brazil.
Bees of the species Apis mellifera were captured from their hives in the apiary of the School of Biological Sciences of the Federal University of Grande Dourados and immediately frozen to avoid metabolic changes. The tea was prepared according to information learned in interviews as follows: ten bees were macerated and placed in 10 mL of hot water (approximately 100°C), which corresponds to approximately 0.1 g of bees per mL of water, for 10 min. After this infusion period, the Apis mellifera tea (AmT) was filtered (Whatman filter paper, grade 40) and kept at 10°C in the refrigerator until use, which was no more than 48 h after preparation.
The AmT was analyzed in an analytical CLAE (Shimadzu), with two LC-20AD pumps, SIL-20A auto-injector, SPD-M20A diode array detector (DAD), CBM-20A controller and CTO-20A oven. The chromatograph was also coupled to a microTOFIII mass spectrometer (Bruker Daltonics) with electrospray ionization source and quadrupole time-of-flight analyzer (Q-TOF). The chromatographic column used was Kinetex C-18 (150 x 2.1 mm, Phenomenex), coupled to a pre-column with the same material. The mobile phase was composed by acetonitrile (B) and deionized water (A), both containing 1% of formic acid (v/v) under a flow rate of 0.3 ml/min and the oven temperature was 50 oC. The gradient method applied was: 0–2 min. 3% B (isocratic), 2–25 min. 3 to 25% B, 25–40 min. 25 to 80% B and 40–43 min. to 80% B (isocratic). Followed by washing and reconditioning the column. The molecular formula of each compound was determined based on the error of up to 5 ppm and mSigma below 30.
ABTS free radical scavenging activity
The antioxidant activity was determined in vitro by studying the scavenging of 2,2 'azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) free radicals, as described previously by Larrauri et al., . For this purpose, AmT was used at concentrations of 5, 50, 100, 500, and 1,000 μg/mL. A total of 20 μL of each AmT concentration was mixed with 1980 μL of ABTS. Ascorbic acid and butyl hydroxytoluene (BHT) standards were prepared at the same concentrations used for AmT, and three independent experiments were performed in duplicate. After 6 min, the absorbance at 734 nm was recorded with a UV/VIS spectrophotometer (PG instruments, Ltd.). The percentage of ABTS radical inhibition was calculated according to Eq 1: (1)
DPPH free radical scavenging activity
Free radical-scavenger activity was determined by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, as described previously by Gupta and Gupta , with some modifications. The antiradical activity of the extracts was evaluated using a dilution series, which involved the mixing of 1.8 mL of DPPH solution (0.11 mM DPPH in 80% ethanol) with 0.2 mL of AmT (5–1000 μg/mL). After 30 min, the remaining DPPH radicals were quantified by absorption at 517 nm. The absorbance of each concentration of the AmT was subtracted from absorbance of the samples with DPPH solution. Ascorbic acid and butylated hydroxytoluene (BHT) were used as reference antioxidants. The tests were performed in duplicate in three independent experiments. DPPH solution without the tested sample was used as a control. The percentage inhibition was calculated from the control with the following Eq 2: (2)
Oxidative hemolysis induced by AAPH
The experimental procedure was submitted to and approved by the Research Ethics Committee involving human beings of the UFGD (authorization No. 1.627.746). The ability of AmT to protect against oxidative hemolysis was evaluated by assessing hemolysis induced by the oxidizing agent 2,2'-azobis (2-methylpropionamidine) dihydrochloride (AAPH) . Fifteen milliliters of human peripheral blood from a single healthy adult individual was collected. The blood was centrifuged at 2,000 rpm, and the plasma and the leukocyte layer were discarded. The erythrocytes were washed three times in 0.9% NaCl, and after washing, a 10% erythrocyte suspension in 0.9% NaCl was prepared. Subsequently, the material was incubated at 37C for 30 min in test tubes in the presence of different concentrations of ascorbic acid or AmT (50, 100, 500, 1000 μg/ml). Subsequently, 0.9% NaCl or 50 mM AAPH was added to evaluate the hemolytic capacity and the inhibition of oxidative hemolysis, respectively. The samples were kept at 37°C for 240 min with periodic stirring. Three independent experiments were performed in duplicate. The percentage of hemolysis was determined by measuring the absorbance at 540 nm and using Eq 3: (3)
Measurement of MDA in human erythrocytes
Lipid peroxidation assays were performed with 10% erythrocyte suspensions. The erythrocytes were incubated at 37°C for 30 min in the presence of different concentrations of ascorbic acid or AmT (50, 100, 500, 1000 μg/ml). Thereafter, 50 mM AAPH was added to the erythrocyte solution and incubated at 37°C for 4 h with periodic stirring. After this period of time, the samples were centrifuged at 2,000 rpm, and 500-μL aliquots of the supernatant were transferred to tubes containing 1 mL of 10 nmol thiobarbituric acid (TBA). As a standard, 500 μL of 20 μM malondialdehyde (MDA) solution was added to 1 mL of TBA. Samples were incubated at 96°C for 45 min. Then, 4 mL of n-butyl alcohol was added and centrifuged at 2,000 rpm. The absorbance of the supernatants was measured at 532 nm. Two independent experiments were performed in triplicate. The concentration of MDA in the samples is expressed in nmol/mL and was obtained from Eq 4: (4)
Oral glucose tolerance test in normoglycemic mice
All experimental animal procedures were submitted to and approved by the UFGD Ethics Committee for Animal Use (authorization No. 25.2016) and performed according to the standards of the National Council for the Control of Animal Experimentation (CONCEA).
The oral glucose tolerance test (OGTT) was performed after 12 hours of fasting in 15 normoglycemic Swiss adult male mice weighing between 55 and 60 g. The mice were given water, metformin (100 mg/kg body weight), or AmT (200 mg/kg body weight), respectively forming the following groups: (1) Control, (2) Metformin, and (3) AmT. After 30 min of treatment, the mice received glucose overload by gavage (2 g/kg body weight). At times 0, 30, 60, 90, 120, and 180 min after the administration of glucose, the glycemia of the mice was measured using caudal venous blood  using the Accu-chek Active (Roche) glucose meter and specific glucose test strips.
Measurement of glycemia and tissue MDA levels in diabetic mice
Approximately 60-day-old normoglycemic Swiss male mice were maintained under controlled temperature (22 ± 2°C) on a 12-hour light, 12-hour dark cycle with free access to food and water.
The mice were fed for 120 days with a control diet (standard Labina feed for rodents) or a high-calorie diet for the induction of hyperglycemia . After this period, blood glucose levels were measured using the Accu-chek Active (Roche®) device and specific glucose test strips. Hyperglycemic mice (glycemia ≥ 200 mg/dL) fed a high-calorie diet were divided randomly (n = 5 per group) and treated for 21 days with water (D-Control Group), 100 mg/kg body weight metformin (D-Metformin Group), or 1 g/mL body weight AmT (D-AmT Group). Normoglycemic mice fed a control diet and water formed the ND-Control Group (n = 5).
At the end of the treatment, the blood glucose level of the mice was measured again. The mice were then anesthetized and euthanized. Arterial blood was collected by cardiac puncture, and the liver, nervous system, and eyes were collected for the measurement of MDA by a method adapted from . Arterial blood samples and tissues were homogenized with 1.15% KCl (potassium chloride) and centrifuged at 3,000 rpm for 10 min. Then, 500 μL of the sample supernatant or 500 μL of the 20 μM MDA standard was added to 1 mL of 10% trichloroacetic acid (TCA) and 1 mL of 10 nmol thiobarbituric acid (TBA) and incubated at 96°C for 45 min. After cooling for 15 min in an ice bath, 3 ml of n-butyl alcohol was added, and the mixture was vortexed and centrifuged at 3,000 rpm for 5 min. Subsequently, the absorbance of 2 mL of the supernatant was measured at 532 nm on a UV/VIS spectrophotometer. The concentration of MDA in the samples is expressed in nmol/mL and was obtained from Eq (5): (5)
Biometric parameters of diabetic mice.
Body weight (g), water consumption (mL), and feed (g) were evaluated three times per week during the 21 days of treatment. In addition, different deposits of white adipose tissue (epididymal, subcutaneous, mesenteric, and retroperitoneal) were removed and weighed after euthanasia.
Glycation inhibition assay
The potential in inhibiting glycation was performed considering the fructose and methylglyoxal pathway as described by Kiho et al., . Bovine serum albumin 8 mg/mL, 0.1mM fructose and 30 mM methylglyoxal were prepared in phosphate buffer 0.2 M, pH 7.4, containing 3 mM sodium azide, as an antimicrobial agent. To 30 μl AmT (1–1000 μg/ml) was mixed with 135 μl of bovine serum albumin and 135 μl of fructose or 135 μl of methylglyoxal. The mixture reaction was incubated at 37ºC for 48 h or 72 h (under sterile conditions in the dark), for inhibition of glycation fructose or glyoxal pathway, respectively. After this period, each sample was examined for the development of fluorescence using a microplate reader DTX 800, Beckman (λex 330 nm and λex 420 nm) against a blank. Quercetin (1–1000 μg/ml) was used as standard. The control consisted of mixing 30 μl of 80% ethanol with 135 μl of bovine serum albumin and 135 μl of fructose or 135 μl methylglyoxal. Three independent experiments were carried out in triplicate. The percentage of inhibition of glycation was obtained by the Eq (6) and IC50 values were obtained by non-linear regressions of the concentration-response curve.(6)
Results are expressed as the means ± standard error of the mean. Analysis of variance (ANOVA) followed by post-test Student-Newman-Keuls analysis was used for multiple comparisons of results, and Student’s t test was used to compare the results of both groups using the Prism 5 GraphPad software. The level of significance was P <0.05.
In the interviews of twenty Guarani and Kaiowá indigenous people aged between 20 and 40 years concerning the animal species used in traditional medicine, 30% described the use of Apis mellifera bee tea for the treatment of diabetes. This use was reported by individuals aged between 30 and 40 years.
The AmT was filtered and analyzed in HPLC-DAD-MS/MS in the positive and negative ionization modes, we observed a significant ionization only in the positive ionization mode (S1 Fig) which was used to characterize Tryptophan derivative, as well as 16 other compounds that still need to be identified (S1 Table).
ABTS and DPPH free radical scavenging.
AmT showed excellent direct antioxidant activity with an IC50 value similar to that of BHT and higher than that of ascorbic acid (Table 1).
AAPH-Induced oxidative hemolysis.
The antioxidant activity of AmT was also confirmed by the scavenging of free radicals generated by AAPH thermolysis in the human erythrocyte assay. AmT efficiently reduced erythrocyte oxidative hemolysis in a dose- and time-dependent manner, similar to all concentrations of ascorbic acid (Fig 1) except for 1,000 μg/mL, a dose at which ascorbic acid behaved as a pro-oxidant substance.
Human erythrocytes incubated with different concentrations (50–1,000 μg/mL) of ascorbic acid (AA) and Apis mellifera bee tea (AmT) (A) 60, (B) 120, and (C) 180 min after the addition of AAPH. Values are presented as the means ± SEM. * P<0.05; ** P<0.01; and *** P<0.001 versus Control sample.
Measurement of MDA in human erythrocytes.
Once protection against oxidative hemolysis was confirmed, its correlation with the reduction of lipid peroxidation was investigated by evaluating the malondialdehyde (MDA) marker in erythrocytes induced with AAPH. Fig 2 indicates that erythrocytes incubated with concentrations greater than 100 μg/mL AmT demonstrated reduced generation of MDA, similar to the observations in erythrocytes incubated with ascorbic acid, except at the highest evaluated concentration of 1,000 μg/mL, at which the ascorbic acid demonstrated pro-oxidant activity.
Malondialdehyde (MDA) concentration 180 min after the addition of the oxidizing agent (AAPH) in erythrocytes incubated with different concentrations (50–1,000 mg/mL) of ascorbic acid (AA) or Apis mellifera bee tea (AmT). Values are presented as the means ± SEM. *P<0.05; **P<0.01; and ***P<0.001 versus Control sample.
Oral glucose tolerance test in normoglycemic mice.
After oral glucose overload, the normoglycemic mice treated with AmT showed a reduced hyperglycemia peak after 30 min and lower blood glucose values at all times evaluated up to 180 min compared to the control mice (Fig 3A). This reduction in serum hyperglycemia can also be observed in the area under the curve, which shows that AmT is more efficient compared with both control and metformin treatment (Fig 3B).
(A) Variation and (B) area under the glycemia curve at 0, 30, 60, and 180 min for mice treated with water, metformin, and AmT after glucose overload. *P<0.05; **P<0.01; and ***P<0.001 versus Control group. #P <0.001 vs. Metformin group.
Glycemia of diabetic mice.
The evaluation of glycemia in high-calorie diet-induced diabetic mice on the first (1st) and last (21st) day of treatment demonstrated the antidiabetic activity of AmT. Fig 4 demonstrates that AmT reduced the hyperglycemia of diabetic mice similarly to treatment with metformin and to normoglycemic controls.
Glycemia in mice from the ND-Control (normoglycemic + water), D-Control (diabetic + water), D-Metformin (diabetic + metformin), and D-AmT (diabetic + AmT) groups on days 1 and 21 of treatment. Values were compared between days 1 and 21 for each experimental group. **P<0.01 and ***P<0.001 versus day 1 of the respective group.
Biometric parameters of diabetic mice.
The biometric parameters evaluated during the treatment are presented in Table 2. The diabetic mice presented reduced body weights compared to normoglycemic mice, although no variation in feed consumption was observed between groups. Water intake of diabetic mice was approximately 3-fold higher than that of normoglycemic mice. Treatment with AmT reduced water intake to similar levels as the normoglycemic control and metformin groups. In addition, a reduction of subcutaneous WAT is seen in diabetic mice treated with water compared to diabetic mice treated with metformin or AmT or to normoglycemic mice. The other WAT deposits evaluated were similar among the groups investigated.
Tissue MDA levels in diabetic mice.
Compared to normoglycemic mice, diabetic mice treated with water (D-Control) presented increased levels of MDA in the arterial blood (76%), liver (64%), nervous system (152%), and eyes (142%) (Fig 5). AmT-treated diabetic mice showed decreased levels of MDA in the blood (37%), liver (37%), nervous system (48%), and eyes (48%) compared to the D-Control group and similar levels as those of the metformin and normoglycemic control groups (Fig 5). No differences were observed in the relative mass of the organs between the evaluated groups.
Groups include ND-Control (normoglycemic + water), D-Control (diabetic + water), D-Metformin (diabetic + metformin), and D-AmT (diabetic + AmT) after 21 days of treatment. Data are presented as the means ± SEM. * P<0.05; ** P<0.01; and ***P <0.001 versus D-Control group.
Glycation inhibition assay.
The potential in inhibiting the formation of advanced glycation end products (AGEs) are presented in Table 3. The AmT was able to inhibit 53.23% of glycation by the methylglyoxal pathway and 98.73% by the fructose pathway.
Traditional indigenous knowledge about zootherapy is the result of centuries of accumulated experiences and cultural practices. However, with increased globalization and interculturality, this knowledge, which remains poorly recorded, is being lost over time. Records and scientific research are needed so that experiences accumulated over centuries will not be lost, thus depriving future generations and other communities of this knowledge. Research surveying zootherapies used in Brazil is a recent development [2,41,42], and no study of the knowledge of the Guarani and Kaiowá ethnicities has been performed. Thus, this study contributes to the maintenance of this information and to cultural revitalization by recording and evaluating the use of Apis mellifera bee tea for the treatment of diabetes.
In the characterization of chemical compounds, compound 1 showed a UV compatible with Tryptophan and an m/z 188.0706 compatible with the tryptophan skeleton without the ammonium group, as well as 16 other compounds that still need to be identified. The ability to tryptophan of reducing the elevation of blood glucose and improving insulin secretion from β-cells  may have contributed for glycemic normalization in diabetic mice treated with AmT. The presence of tryptophan in the blood has been considered a marker of lower risk of diabetes development . For the other compounds we observed two series of compounds, compounds 3 and 4 with the formulas C15H22O9 and C16H24O10, respectively, both without significant UV absorption and without MS/MS fragments. The search for similar compounds in the literature did not return results. The second series as formed by the compounds number 2, 5–17 which have two nitrogen in their composition with increasing carbonic chain length (C10 to C20), in addition to 1 or 2 oxygen, no one of these compounds also absorbed in the UV spectrum. Again the search for compatible compounds in literature did not return positive results. Several authors demonstrate the presence of waxes in the body composition of bees and other insects, but these do not present nitrogen in their composition [43, 44]. We believe that both classes of compounds could be new in the literature; unfortunately a positive characterization will require other work with this focus.
Oxidative stress promotes insulin secretion defects, decreases insulin sensitivity in peripheral tissues, and causes other complications associated with diabetes, and oxidative stress control is helpful in diabetes treatment . Antioxidant activity is important in biological systems exposed to excess reactive species. For example, muscle cells cultured in the presence of an ROS inducer show reduced glucose uptake that is overcome upon treatment with antioxidant substances [45, 46].
In the present study, AmT showed potential antioxidant, antihyperglycemic, and antidiabetic activities. The antioxidant activity of AmT was demonstrated in vitro by the direct scavenging of ABTS and DPPH reactive species, the inhibition of lipid peroxidation induced by AAPH, and the reduction of oxidative hemolysis and malondialdehyde production in human erythrocytes. The peroxidation of polyunsaturated fatty acids in the cell membrane, which is induced by excess free radicals , causes damage and cell death  and the release of malondialdehyde (MDA), a byproduct derivative of lipid peroxidation . Our results suggest a synergy between compounds with antioxidant properties obtained from macerated whole bees compared to synthetic antioxidants, ascorbic acid, and BHT. Recently,  observed that Apis mellifera iberiensis bee venom had antioxidant activity, but they could not attribute this activity to the major compounds, which were identified as melittin, phospholipase A2, and apamine.
The antihyperglycemic activity of AmT was indicated in vivo by the control of postprandial hyperglycemia in normoglycemic mice subjected to glucose overload, and this activity was similar to that of metformin. Although the main cellular damage related to diabetes is caused by prolonged exposure to hyperglycemia, strategies to control postprandial hyperglycemia peaks have been associated with reduced vascular damage in diabetic patients [51, 52]. Considering the short time between the administration of AmT and improved glycemic control, it is possible to infer that rapidly acting mechanisms are being activated, such as GLUT4 translocation in skeletal muscle tissue and white adipose tissue  or the activation of kinases, which is important in processes related to insulin sensitivity and glucose uptake , but these mechanisms still need to be investigated. Additionally, , reported that the administration of bee venom (apitoxin) in alloxan-induced diabetic rats increased serum insulin secretion and reduced blood glucose levels. However, melittin, the main constituent of apitoxin, improves insulin sensitivity through the activation of phospholipase A2 in diabetic mice induced by diet . Both apitoxin and melittin may have contributed to the glycemic control observed in this study, although insulin resistance is the predominant mechanism that triggers diet-induced diabetes [57, 58, 59], which was the model used in this study.
In addition, in diabetic mice treated with AmT, the reduction of glycemic parameters to levels similar to metformin and normoglycemic controls and the reduction of lipid peroxidation were observed in the different tissues and organs evaluated.
The involvement of oxidative stress in the etiology and progression of diabetes has created opportunities for the development of antidiabetic therapies linked to the blockade of oxidative pathways with the use of antioxidant substances [40, 60]. In diabetes, hyperglycemia intensifies oxidative stress through mechanisms involving increased aldose reductase enzyme activity, protein kinases , and formation of advanced glycation end products . Protein glycation occurs commonly in non-enzymatic reactions, called the Maillard reaction, occurring between free amino groups of proteins and carbonyl groups of reducing sugars such as glucose, fructose, pentoses, galactose, mannose and xylulose, forming a compound unstable, the Schiff base, which undergoes a rearrangement to a more stable product known as Amadori product . The Amadori product degrades to a variety of reactive dicarbonyl compounds, such as methylglyoxal and deoxyglucosones, by dehydration, oxidation and other chemical reactions . In the formation of AGEs, reactive oxygen species can be generated and increase oxidative stress leading to structural and functional damage of macromolecules [40, 63, 64]. The ability of AmT to inhibit the formation of AGEs by fructose pathways was nine times more significant than the inhibition of the reaction of methylglyoxal products, increasing the possibility that this is one of the mechanisms of action of the AmT, contributing to the improvement of glycemic control and complications of diabetes. Metformin is effective in the control of diabetes because it has antioxidant and antihyperglycemic activities that are mediated by different mechanisms [65, 66].
The periodic evaluation of lipid peroxidation products in diabetes is recommended because their detection and early treatment reduce the diabetic complications, such as endothelial dysfunction, neuropathy, and retinopathy, that are mediated by excess reactive species reaching different tissues [67, 68]. The protective effect of AmT was indicated by the reduction of lipid peroxidation in the organs and tissues of diabetic mice; these mice presented levels of MDA similar to normoglycemic animals at the end of treatment. This effect was also observed in diabetic rats treated with combinations of probiotics and vitamin C . In addition, parameters that demonstrate improvement in diabetes, such as the normalization of water intake and the maintenance of the deposition of subcutaneous white adipose tissue [33, 70], were observed in this study.
Apis mellifera bee tea, a traditional diabetes treatment used by the indigenous Guarani and Kaiowá people groups, in this study showed potential antioxidant, and was efficient in controlled the postprandial hyperglycemia of normoglycemic mice, and normalized glycemia in diabetic mice. These data are important because they contribute to the recording of traditional zootherapeutic knowledge used for the treatment of diabetes.
S1 Text. Semi-structured interview model applied to register traditional knowledge.
S1 Fig. Chromatography profile of the Apis mellifera Tea (AmT).
S1 Table. Compounds characterized by HPLC-DAD-MS/MS in Apis mellifera Tea (AmT).
The authors thank the support funding of Foundation for Support to the Development of Education, Science and Technology of Mato Grosso do Sul—FUNDECT, the National Council for Scientific and Technological Development—CNPq, and the Brazilian Federal Agency for the Support and Evaluation of Graduate Education—CAPES, and FUNDECT/CAPES No. 27/2015 –PAPOS FASE III.
- 1. Costa-neto EM. Healing with animals in Feira de Santana City, Bahia, Brazil. 1999;65(March 1998):225–30. pmid:10404420
- 2. Alves RRN, Alves HN. The faunal drugstore: Animal-based remedies used in traditional medicines in Latin America. J Ethnobiol Ethnomed [Internet]. BioMed Central Ltd; 2011;7(1):9. Available from: http://www.ethnobiomed.com/content/7/1/9doi:10.1186/1746-4269-7-9.
- 3. Lev E. Traditional healing with animals (zootherapy): Medieval to present-day Levantine practice. J Ethnopharmacol. 2003;85(1):107–18. pmid:12576209
- 4. Maurício J, Bankova V. Propolis: Is there a potential for the development of new drugs? 2011;133:253–60. pmid:20970490
- 5. Nazrul-Islam SK. Ferdous AJ, Hassan CM. Hassan M, Sultana S. Screening of honey for its antibacterial properties against pathogenic bacteria including resistant strains of Shigella. Fitoterapia-Milano.1993;64(2): 176–178.
- 6. Takzaree N, Hassanzadeh G, Rouini MR. Evaluation of the Effects of Local Application of Thyme Honey in Open Cutaneous Wound Healing. Iranian Journal of Public Health. 2017;46(4):545–51. pmid:28540272
- 7. Campos JF, Pereira U, Damião MJ, Benedito J, Balestieri P, Andrea C, et al.Antimicrobial, Antioxidant, Anti-Inflammatory, and Cytotoxic Activities of Propolis from the Stingless Bee Tetragonisca fiebrigi (Jataí). Evid Based Complement Alternat Med. 2015;2015. .
- 8. Bonamigo T, Campos JF, Alfredo TM, Benedito J, Balestieri P, Andrea C, et al.Oxid Med Cell Longev. 2017;1038153.
- 9. Behroozi J, Divsalar A, Saboury AA. Honey bee venom decreases the complications of diabetes by preventing hemoglobin glycation. J Mol Liq [Internet]. Elsevier B.V.; 2014;199:371–5. Available from: http://dx.doi.org/10.1016/j.molliq.2014.09.034
- 10. Park JH, Park B, Park KK. Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGF_/Smad and MAPK-JNK Signaling Pathways. Toxins. 2017;9(4), 138; .
- 11. Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;402:16–31. pmid:28536009
- 12. Inubushi T, Kamemura N, Oda M, Sakurai J, Nakaya Y, Harada N, et al. L-tryptophan suppresses rise in blood glucose and preserves insulin secretion in type-2 diabetes mellitus rats. J Nutr Sci Vitaminol (Tokyo) [Internet]. 2012;58(6):415–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23419400
- 13. Chen T, Zheng X, Ma X, et al. Tryptophan Predicts the Risk for Future Type 2 Diabetes. Guillemin GJ, ed. PLoS ONE. 2016;11(9):e0162192. pmid:27598004
- 14. Khalil SR, Abd-Elhakim YM, Selim ME, Al-Ayadhi LY. Apitoxin protects rat pups brain from propionic acid-induced oxidative stress: The expression pattern of Bcl-2 and Caspase-3 apoptotic genes. Neurotoxicology. 2015;49:121–31. pmid:26048086
- 15. Azman KF, Zakaria R, Abdul Aziz CB, Othman Z. Tualang Honey Attenuates Noise Stress-Induced Memory Deficits in Aged Rats. Oxidative Medicine and Cellular Longevity. 2016;2016:1549158. pmid:27119005
- 16. Shibata T, Shibata S, Shibata N, et al. Propolis, a Constituent of Honey, Inhibits the Development of Sugar Cataracts and High-Glucose-Induced Reactive Oxygen Species in Rat Lenses. Journal of Ophthalmology. 2016;2016:1917093. pmid:27242920
- 17. Larrauri JA, Rupérez P, Saura-Calixto F. Effect of drying temperature on the stability of polyphenols and antioxidant activity of red grape pomace peels. J Agric Food Chem. 1997;45:1390–3. .
- 18. Leonarduzzi G, Sottero B, Poli G. Targeting tissue oxidative damage by means of cell signaling modulators: The antioxidant concept revisited. Pharmacol Ther [Internet]. Elsevier Inc.; 2010;128(2):336–74. Available from: http://dx.doi.org/10.1016/j.pharmthera.2010.08.003 pmid:20732353
- 19. Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai. 2010;93(6):682–93. pmid:20572373
- 20. Fatani SH, Babakr AT, NourEldin EEM, Almarzouki AA. Lipid peroxidation is associated with poor control of type-2 diabetes mellitus. Diabetes Metab Syndr Clin Res Rev. 2016; 2016;(15)30061–8. .
- 21. Magder S. Reactive oxygen species: toxic molecules or spark of life? 2006;8:1–8. .
- 22. Svilar D, Goellner EM, Almeida KH, Sobol RW. Base Excision Repair and Lesion-Dependent Subpathways for Repair of Oxidative DNA Damage. Antioxidants & Redox Signaling. 2011;14(12):2491–2507. .
- 23. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, et al. Diabetic Nephropathy: Mechanisms of Renal Disease Progression. Exp Biol Med [Internet]. 2008;233(1):4–11. Available from: http://ebm.rsmjournals.com/cgi/doi/10.3181/0705-MR-134.
- 24. Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008;9(4):315–27. pmid:18654858
- 25. Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: The oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9(4):301–14. pmid:18709457
- 26. Baynes JW. Role of Oxidative Stress in Development of Complications in Diabetes. Diabetes [Internet]. 1991;40(4):405–12. Available from: http://diabetes.diabetesjournals.org/cgi/doi/10.2337/diab.40.4.405 pmid:2010041
- 27. Kokil GR, Veedu RN, Ramm GA, Prins JB, Parekh HS. Type 2 Diabetes Mellitus: Limitations of Conventional Therapies and Intervention with Nucleic Acid-Based Therapeutics. 2014;10;115(11):4719–43. .
- 28. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract [Internet]. Elsevier Ireland Ltd; 2014;103(2):137–49. Available from: http://dx.doi.org/10.1016/j.diabres.2013.11.002 pmid:24630390
- 29. Noeman S, Hamooda HE, Baalash AA. Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetol Metab Syndr. 2011;3(1):17. pmid:21812977
- 30. Emami SR, Jafari M, Haghshenas R, Ravasi A. Impact of eight weeks endurance training on biochemical parameters and obesity-induced oxidative stress in high fat diet-fed rats. J Exerc Nutr Biochem [Internet]. 2016;20(1):30–6. Available from: http://jenb.or.kr/_common/do.php?a=full&bidx=489&aidx=6156.
- 31. Hjartåker A, Langseth H, Weiderpass E. Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol. 2008;630: 72–93. pmid:18637486
- 32. Nunes-souza V, César-gomes CJ, José L, Da S, Da G, Guedes S, et al. Aging Increases Susceptibility to High Fat Diet-Induced Metabolic Syndrome in C57BL / 6 Mice: Improvement in Glycemic and Lipid Profile after Antioxidant Therapy. 2016;2016. pmid:27057272
- 33. Kang YM, Kim F, Lee WJ. Role of NO / VASP Signaling Pathway against Obesity- Related Inflammation and Insulin Resistance. Diabetes Metab J. 2017;89–95. pmid:28447436
- 34. El-sayed MK. Effects of Portulaca oleracea L. seeds in treatment of type-2 diabetes mellitus patients as adjunctive and alternative therapy. J Ethnopharmacol [Internet]. Elsevier Ireland Ltd; 2011;137(1):643–51. Available from: http://dx.doi.org/10.1016/j.jep.2011.06.020 pmid:21718775
- 35. Umeno A, Horie M, Murotomi K, Nakajima Y, Yoshida Y. Antioxidative and Antidiabetic Effects of Natural Polyphenols and Isoflavones. Molecules. 2016; 21(6):708doi: 10.3390/molecules21060708.
- 36. Gupta D, Gupta RK. Bioprotective properties of Dragon’s blood resin: In vitro evaluation of antioxidant activity and antimicrobial activity. BMC Complement Altern Med. 2011;11.doi: 10.1186/1472-6882-11-13.
- 37. Ferreira J, Pereira U, Fernando L, Macorini B, Mary A, Benedito J, et al. Antimicrobial, antioxidant and cytotoxic activities of propolis from Melipona orbignyi (Hymenoptera, Apidae ). FOOD Chem Toxicol [Internet]. Elsevier Ltd; 2014;(January). Available from: http://dx.doi.org/10.1016/j.fct.2014.01.008
- 38. Aragão DMO, Guarize L, Lanini J, Juliana C, Garcia RMG, Scio E. Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats.J Ethnopharmacol. 2010;128:629–33. pmid:20064597
- 39. Draper HH, Squires EJ, Mahmoodi H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radic Biol Med. 1993;15(4):353–63. . pmid:8225017
- 40. KIHO T, USUI S, HIRANO K, AIZAWA K, INAKUMA T. Tomato Paste Fraction Inhibiting the Formation of Advanced Glycation End-products. Biosci Biotechnol Biochem [Internet]. 2004;68(1):200–5. Available from: http://www.tandfonline.com/doi/full/10.1271/bbb.68.200 pmid:14745184
- 41. Barros BF, Varela SAM, Pereira HM, Vicente L. Medicinal use of fauna by a traditional community in the Brazilian Amazonia Medicinal use of fauna by a traditional community in the Brazilian Amazonia. Ethnobiol Ethnomedicine. 2012;8(1):1–19. .
- 42. Chaves TP, Clementino ELC, Felismino DC, Alves RRN, Vasconcellos A, Coutinho HDM, et al. Antibiotic resistance modulation by natural products obtained from Nasutitermes corniger (Motschulsky, 1855) and its nest. Saudi J Biol Sci. 2015;22(4):404–8. pmid:26150745
- 43. Tulloch AP. The composition of beeswax and other waxes secreted by insects. Lipids. 1970;5(2):247–58. .
- 44. Fratini F, Cilia G, Turchi B, Felicioli A. Beeswax: A minireview of its antimicrobial activity and its application in medicine. Asian Pac J Trop Med [Internet]. Elsevier B.V.; 2016;9(9):839–43. Available from: http://dx.doi.org/10.1016/j.apjtm.2016.07.003 pmid:27633295
- 45. Dhanya R, Arun KB, Nisha VM, Syama HP, Nisha P, Kumar TRS. Preconditioning L6 Muscle Cells with Naringin Ameliorates Oxidative Stress and Increases Glucose Uptake. 2015;1–11. Available from: http://dx.doi.org/10.1371/journal.pone.0132429
- 46. Krishna MS, Joy B, Sundaresan A. Effect on oxidative stress, glucose uptake level and lipid droplet content by Apigenin 7, 4’-dimethyl ether isolated from Piper longum L. J Food Sci Technol. 2015;52(6):3561–70. pmid:26028738
- 47. Kuliaviene I, Gulbinas A, Cremers J, Pundzius J, Kupcinskas L, et al. Fatty acids of erythrocyte membrane in acute pancreatitis patients. World J Gastroenterol. 2013;19:5678–84. pmid:24039361
- 48. Chisté RC, Freitas M, Mercadante AZ, Fernandes E. Carotenoids inhibit lipid peroxidation and hemoglobin oxidation, but not the depletion of glutathione induced by ROS in human erythrocytes. Life Sci [Internet]. Elsevier B.V.; 2014;99(1–2):52–60. Available from: http://dx.doi.org/10.1016/j.lfs.2014.01.059. pmid:24486304
- 49. Haider L, Fischer MT, Frischer JM, Bauer J, Höftberger R, Botond G, et al. Oxidative damage in multiple sclerosis lesions. Brain. 2011;134(7):1914–24. .
- 50. Sobral F, Sampaio A, Falcão S, Queiroz MJRP, Ricardo C, Vilas-boas M, et al. Chemical characterization, antioxidant, anti-inflammatory and cytotoxic properties of bee venom collected in Northeast Portugal.; Food Chem Toxicol. 2016;94:172–177. pmid:27288930
- 51. American Diabetes Association. Postprandial Blood Glucose. Diabetes Care. 2001;24(4): 775–778. . pmid:11315848
- 52. Parkin CG, Brooks N., 2002. Is Postprandial Glucose Control Important? Is It Practical In Primary Care Settings? Clinical Diabetes. 2002; 20(2): 71–76. Available from: http://dx.doi.org/10.2337/diaclin.20.2.71.
- 53. Kurth-Kraczek EJ, Hirshman MF, Goodyear LJ, Winder WW.5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes. 1999;48:1667–1671. . pmid:10426389
- 54. Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, et al. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 2005;289(4):E643–9 pmid:15928020
- 55. Mousavi SM, Imani S, Haghighi S, Mousavi SE, Karimi A., 2012. Effect of Iranian Honey bee (Apis mellifera) Venom on Blood Glucose and Insulin in Diabetic Rats. J Arthropod Borne Dis. 2012;6(2):136–43. pmid:23378971
- 56. Simonsson E, Karlsson S, Ahre B, Aa MH. Islet Phospholipase A 2 Activation Is Potentiated in Insulin Resistant Mice.Biochem Biophys Res Communi. 2000;543:539–43.
- 57. Kang YH, Cho MH, Kim JY, Kwon MS, Peak JJ, Kang SW, Yoon SY, Song Y. Impaired macrophage autophagy induces systemic insulin resistance in obesity. Oncotarget. 2016; 7:35577–35591. pmid:27229537
- 58. Becattini B, Zani F, Breasson L, Sardi C, Agostino VGD, Choo M, et al. JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damage.FASEB J. 2016;26.pii:fj.201600393R. .
- 59. Zhao F, Pang W, Zhang Z, Zhao J, Wang X, Liu Y, et al. Pomegranate extract and exercise provide additive benefits on improvement of immune function by inhibiting inflammation and oxidative stress in high-fat-diet-induced obesity rats. J Nutr Biochem [Internet]. Elsevier Inc.; 2016;32:20–8. Available from: http://dx.doi.org/10.1016/j.jnutbio.2016.02.003 pmid:27142733
- 60. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(December):813–20. pmid:11742414
- 61. Osawa T, Kato Y. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci. 2005;1043:440–51. pmid:16037265
- 62. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006;212:167–78. pmid:16490224
- 63. Monnier VM, Nagaraj RH, Portero-Otin M, Glomb M, Elgawish AH, Sell DR, Friedlander MA. Structure of advanced Maillard reaction products and their pathological role. Nephrol Dial Transplant. 1996;11 Suppl 5:20–6
- 64. Singh VP, Bali A, Singh N, Jaggi AS. Advanced Glycation End Products and Diabetic Complications. Korean J Physiol Pharmacol. 2014;18(1):1–14. pmid:24634591
- 65. Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem Biol Interact. 2011;192(3) 233–242. pmid:21457706
- 66. Marycz K, Tomaszewski KA, Kornicka K, Henry BM, N SW, Tarasiuk J, et al. Metformin Decreases Reactive Oxygen Species, Enhances Osteogenic Properties of Adipose-Derived Multipotent Mesenchymal Stem Cells In Vitro, and Increases Bone Density In Vivo. Hindawi Publishing Corporation; 2016;2016. https://doi.org/10.1155/2016/9785890.
- 67. Avogaro A, Albiero M, Menegazzo L, De Kreutzenberg S, Fadini GP. Endothelial dysfunction in diabetes: The role of reparatory mechanisms. Diabetes Care. 2011;34(SUPPL. 2):285–90.
- 68. Cao A, Wang L, Chen X, Guo H, Chu S, Zhang X. Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress. 2016;39(8):1300–8. pmid:27193377
- 69. Aluwong T, Ayo JO, Kpukple A, Oladipo OO. Amelioration of Hyperglycaemia, Oxidative Stress and Dyslipidaemia in Alloxan-Induced Diabetic Wistar Rats Treated with Probiotic and Vitamin C. Nutrients. 2016;1–15.
- 70. Zhang Y, Wu L, Ma Z, Cheng J, Liu J. Anti-Diabetic, Anti-Oxidant and Anti-Hyperlipidemic Activities of Flavonoids from Corn Silk on STZ-Induced Diabetic Mice. Molecules. 2016; 21(1):7doi: 10.3390/molecules21010007.